REFERENCES
- Sargsyan SA, Monk PN, Shaw 11. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 2005; 51: 241–253
- Clement AM, Nguyen MD, Roberts EA, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003; 302: 113–117
- Corti S, Locatelli F, Donadoni C, et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skelet al muscle tissues. Brain 2004; 127: 2518–2532
- Chi L, Ke Y, Luo C, et al. Motor neuron degeneration promotes neural progenitor cell proliferation, migration and neurogenesis in the spinal cords of ALS mice. Stem Cells 2006; 24: 34–43
- Svendsen CN, Langston JW. Stem cells for Parkinson disease and ALS: Replacement or protection? Nat Med 2004; 10: 224–225
- Klein SM, Behrstock S, McHugh J, et al. GDNF Delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 2005; 16: 509–521
- Tohill M, Mantovani C, Wiberg M, et al. Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neurosci Lett 2004; 362: 200–203
- Bae YS, Furuya S, Shinoda Y. Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick type C mice. Hum Gene Ther 2005; 16: 1006–1011
- Bossolasco P, Cova L, Calzarossa C, et al. Neuro-glial differentia-tion of human bone marrow stem cells in vitro. Exp Neurol 2005; 193: 312–325
- Dezawa M, Takahashi I, Esaki M, et al. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci 2001; 14: 1771–1776
- Akiyama Y, Radtke C, Honmou O, et al. Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 2002; 39: 229–236
- Jiang Y, Yahagirdaz BN, Reinbardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–49
- Tzeng SF, Tsai MJ, Hung SC, et al. Neuronal morphological change of size-sieved stem cells induced by neurotrophic stimuli. Neurosci Lett 2004; 367: 23–28
- Li Y, Chen J, Wang L, et al. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine mouse model of Parkinson's disease. Neurosci Lett 2001; 316: 67–70
- Gao Q, Li Y, Chopp M. Bone marrow stromal cells increase astrocyte survival via upregulation of phosphoinositide 3-kinase/ threonine protein kinase and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways and stimu-late astrocyte trophic factor gene expression after anaerobic insult. Neuroscience 2005; 136: 123-134
- Kurozumi K, Nakamura K, Tamiya T, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005; 11: 96-104
- Mareschi K, Biasin E, Piacibello, et al. Isolation of human mesenchymal stem cells: Bone marrow versus umbilical cord blood. Haematologica 2001; 86: 1099–1100
- Mareschi K, Ferrero I, Rustichelli, et al. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 2006; 97: 744–754
- Mazzini L, Fagioli F, Boccaletti R, et al. Stem cell therapy in amyotrophic lateral sclerosis: A methodological approach in humans. Amyotroph Lateral Scier Other Motor Neuron Disord 2003; 4: 158–161
- Mazzini L, Fagioli F, Boccaletti R. Stem-cell therapy in amyo-trophic lateral sclerosis. Lancet 2004; 364: 1936–1937